Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Feb;32(2):31.
doi: 10.1007/s11274-015-1986-z. Epub 2016 Jan 9.

Archetypal tryptophan-rich antimicrobial peptides: properties and applications

Affiliations
Review

Archetypal tryptophan-rich antimicrobial peptides: properties and applications

Nadin Shagaghi et al. World J Microbiol Biotechnol. 2016 Feb.

Abstract

Drug-resistant microorganisms ('superbugs') present a serious challenge to the success of antimicrobial treatments. Subsequently, there is a crucial need for novel bio-control agents. Many antimicrobial peptides (AMPs) show a broad-spectrum activity against bacteria, fungi or viruses and are strong candidates to complement or substitute current antimicrobial agents. Some AMPs are also effective against protozoa or cancer cells. The tryptophan (Trp)-rich peptides (TRPs) are a subset of AMPs that display potent antimicrobial activity, credited to the unique biochemical properties of tryptophan that allow it to insert into biological membranes. Further, many Trp-rich AMPs cross bacterial membranes without compromising their integrity and act intracellularly, suggesting interactions with nucleic acids and enzymes. In this work, we overview some archetypal TRPs derived from natural sources, i.e., indolicidin, tritrpticin and lactoferricin, summarising their biochemical properties, structures, antimicrobial activities, mechanistic studies and potential applications.

Keywords: Antimicrobial agents; Antimicrobial peptides (AMP); Mechanisms of action; Trp-rich peptides (TRP); Tryptophan.

PubMed Disclaimer

References

    1. J Biol Chem. 1999 Aug 13;274(33):23296-304 - PubMed
    1. Int J Antimicrob Agents. 2009 Nov;34(5):457-61 - PubMed
    1. J Biol Chem. 2005 Jan 14;280(2):1448-56 - PubMed
    1. J Biol Chem. 1985 Apr 25;260(8):4579-84 - PubMed
    1. Colloids Surf B Biointerfaces. 2012 Dec 1;100:95-102 - PubMed

MeSH terms

LinkOut - more resources